APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Human Transforming Growth Factor-β

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Recombinant Human Transforming Growth Factor-β Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025199 pages

Choose your research edition.

Industry ResearchRecombinant Human Transforming Growth Factor-β Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Human Transforming Growth Factor-β Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Recombinant Human Transforming Growth Factor-β Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Human Transforming Growth Factor-β Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Human Transforming Growth Factor-β Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Recombinant Human Transforming Growth Factor-β market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Recombinant Human Transforming Growth Factor-β is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Recombinant Human Transforming Growth Factor-β is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Human Transforming Growth Factor-β is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Recombinant Human Transforming Growth Factor-β is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Recombinant Human Transforming Growth Factor-β include Abcam, ACROBiosystems, Atlantis Bioscience, Bio-Techne, Cell Guidance Systems, Cell Signaling Technology, Croyez Bioscience, FUJIFILM Irvine Scientific and MedChemExpress, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Recombinant Human Transforming Growth Factor-β market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Recombinant Human Transforming Growth Factor-β and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Recombinant Human Transforming Growth Factor-β sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Recombinant Human Transforming Growth Factor-β market size, projected growth trends, production technologies, key applications, and end-use industries.

Recombinant Human Transforming Growth Factor-β Segment by Company

Abcam

ACROBiosystems

Atlantis Bioscience

Bio-Techne

Cell Guidance Systems

Cell Signaling Technology

Croyez Bioscience

FUJIFILM Irvine Scientific

MedChemExpress

Miltenyi Biotec

Proteintech

Qkine

Sigma-Aldrich

Beijing T&L Biotechnology

Beijing Sino Biological

Dalian Meilun Biotechnology

Cellverse

Nanjing Okay Biotechnology

Thermo Fisher

Shanghai DiLab Biotechnology

Shanghai Zhong Qiao Xin Zhou Biotechnology

Suzhou Novoprotein Scientific

Abbkine Scientific

EIAAB SCIENCE

Yeasen Biotechnology (Shanghai)

Recombinant Human Transforming Growth Factor-β Segment by Type

TGF-β3

TGF-β2

TGF-β1

Recombinant Human Transforming Growth Factor-β Segment by Application

Hospital

Research Institute

Others

Recombinant Human Transforming Growth Factor-β Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Human Transforming Growth Factor-β market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Human Transforming Growth Factor-β and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Human Transforming Growth Factor-β.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Recombinant Human Transforming Growth Factor-β market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Recombinant Human Transforming Growth Factor-β manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Recombinant Human Transforming Growth Factor-β in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Recombinant Human Transforming Growth Factor-β in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Recombinant Human Transforming Growth Factor-β Industry Trends Table 2. Recombinant Human Transforming Growth Factor-β Industry Drivers Table 3. Recombinant Human Transforming Growth Factor-β Industry Opportunities and Challenges Table 4. Recombinant Human Transforming Growth Factor-β Industry Restraints Table 5. Global Recombinant Human Transforming Growth Factor-β Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Recombinant Human Transforming Growth Factor-β Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Manufacturers Table 9. Global Recombinant Human Transforming Growth Factor-β Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Recombinant Human Transforming Growth Factor-β Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Recombinant Human Transforming Growth Factor-β Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Recombinant Human Transforming Growth Factor-β Manufacturers, Product Type & Application Table 13. Global Recombinant Human Transforming Growth Factor-β Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Recombinant Human Transforming Growth Factor-β by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of TGF-β3 Table 17. Major Manufacturers of TGF-β2 Table 18. Major Manufacturers of TGF-β1 Table 19. Global Recombinant Human Transforming Growth Factor-β Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2026) & (K Units) Table 21. Global Recombinant Human Transforming Growth Factor-β Sales by Type (2027-2032) & (K Units) Table 22. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2021-2026) Table 23. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2027-2032) Table 24. Global Recombinant Human Transforming Growth Factor-β Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2026) & (K Units) Table 26. Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2027-2032) & (K Units) Table 27. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2021-2026) Table 28. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Research Institute Table 31. Major Manufacturers of Others Table 32. Global Recombinant Human Transforming Growth Factor-β Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2026) & (K Units) Table 34. Global Recombinant Human Transforming Growth Factor-β Sales by Application (2027-2032) & (K Units) Table 35. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2021-2026) Table 36. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2027-2032) Table 37. Global Recombinant Human Transforming Growth Factor-β Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2026) & (K Units) Table 39. Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2027-2032) & (K Units) Table 40. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2021-2026) Table 41. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2027-2032) Table 42. Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Recombinant Human Transforming Growth Factor-β Sales by Region (2021-2026) & (K Units) Table 44. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Region (2021-2026) Table 45. Global Recombinant Human Transforming Growth Factor-β Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Recombinant Human Transforming Growth Factor-β Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Recombinant Human Transforming Growth Factor-β Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 49. North America Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032) & (K Units) Table 50. Europe Recombinant Human Transforming Growth Factor-β Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 52. Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (2027-2032) & (K Units) Table 59. Global Recombinant Human Transforming Growth Factor-β Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Recombinant Human Transforming Growth Factor-β Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Recombinant Human Transforming Growth Factor-β Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2021-2026) Table 63. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2027-2032) Table 64. Abcam Company Information Table 65. Abcam Business Overview Table 66. Abcam Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Abcam Recombinant Human Transforming Growth Factor-β Product Portfolio Table 68. Abcam Recent Development Table 69. ACROBiosystems Company Information Table 70. ACROBiosystems Business Overview Table 71. ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. ACROBiosystems Recombinant Human Transforming Growth Factor-β Product Portfolio Table 73. ACROBiosystems Recent Development Table 74. Atlantis Bioscience Company Information Table 75. Atlantis Bioscience Business Overview Table 76. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio Table 78. Atlantis Bioscience Recent Development Table 79. Bio-Techne Company Information Table 80. Bio-Techne Business Overview Table 81. Bio-Techne Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Bio-Techne Recombinant Human Transforming Growth Factor-β Product Portfolio Table 83. Bio-Techne Recent Development Table 84. Cell Guidance Systems Company Information Table 85. Cell Guidance Systems Business Overview Table 86. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product Portfolio Table 88. Cell Guidance Systems Recent Development Table 89. Cell Signaling Technology Company Information Table 90. Cell Signaling Technology Business Overview Table 91. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 93. Cell Signaling Technology Recent Development Table 94. Croyez Bioscience Company Information Table 95. Croyez Bioscience Business Overview Table 96. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio Table 98. Croyez Bioscience Recent Development Table 99. FUJIFILM Irvine Scientific Company Information Table 100. FUJIFILM Irvine Scientific Business Overview Table 101. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 103. FUJIFILM Irvine Scientific Recent Development Table 104. MedChemExpress Company Information Table 105. MedChemExpress Business Overview Table 106. MedChemExpress Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. MedChemExpress Recombinant Human Transforming Growth Factor-β Product Portfolio Table 108. MedChemExpress Recent Development Table 109. Miltenyi Biotec Company Information Table 110. Miltenyi Biotec Business Overview Table 111. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product Portfolio Table 113. Miltenyi Biotec Recent Development Table 114. Proteintech Company Information Table 115. Proteintech Business Overview Table 116. Proteintech Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Proteintech Recombinant Human Transforming Growth Factor-β Product Portfolio Table 118. Proteintech Recent Development Table 119. Qkine Company Information Table 120. Qkine Business Overview Table 121. Qkine Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Qkine Recombinant Human Transforming Growth Factor-β Product Portfolio Table 123. Qkine Recent Development Table 124. Sigma-Aldrich Company Information Table 125. Sigma-Aldrich Business Overview Table 126. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product Portfolio Table 128. Sigma-Aldrich Recent Development Table 129. Beijing T&L Biotechnology Company Information Table 130. Beijing T&L Biotechnology Business Overview Table 131. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 133. Beijing T&L Biotechnology Recent Development Table 134. Beijing Sino Biological Company Information Table 135. Beijing Sino Biological Business Overview Table 136. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product Portfolio Table 138. Beijing Sino Biological Recent Development Table 139. Dalian Meilun Biotechnology Company Information Table 140. Dalian Meilun Biotechnology Business Overview Table 141. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 143. Dalian Meilun Biotechnology Recent Development Table 144. Cellverse Company Information Table 145. Cellverse Business Overview Table 146. Cellverse Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Cellverse Recombinant Human Transforming Growth Factor-β Product Portfolio Table 148. Cellverse Recent Development Table 149. Nanjing Okay Biotechnology Company Information Table 150. Nanjing Okay Biotechnology Business Overview Table 151. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 153. Nanjing Okay Biotechnology Recent Development Table 154. Thermo Fisher Company Information Table 155. Thermo Fisher Business Overview Table 156. Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Thermo Fisher Recombinant Human Transforming Growth Factor-β Product Portfolio Table 158. Thermo Fisher Recent Development Table 159. Shanghai DiLab Biotechnology Company Information Table 160. Shanghai DiLab Biotechnology Business Overview Table 161. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 163. Shanghai DiLab Biotechnology Recent Development Table 164. Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information Table 165. Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview Table 166. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 167. Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio Table 168. Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Development Table 169. Suzhou Novoprotein Scientific Company Information Table 170. Suzhou Novoprotein Scientific Business Overview Table 171. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 172. Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 173. Suzhou Novoprotein Scientific Recent Development Table 174. Abbkine Scientific Company Information Table 175. Abbkine Scientific Business Overview Table 176. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 177. Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio Table 178. Abbkine Scientific Recent Development Table 179. EIAAB SCIENCE Company Information Table 180. EIAAB SCIENCE Business Overview Table 181. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 182. EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product Portfolio Table 183. EIAAB SCIENCE Recent Development Table 184. Yeasen Biotechnology (Shanghai) Company Information Table 185. Yeasen Biotechnology (Shanghai) Business Overview Table 186. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 187. Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product Portfolio Table 188. Yeasen Biotechnology (Shanghai) Recent Development Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Recombinant Human Transforming Growth Factor-β Distributors List Table 192. Recombinant Human Transforming Growth Factor-β Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Recombinant Human Transforming Growth Factor-β Product Image Figure 2. Global Recombinant Human Transforming Growth Factor-β Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Human Transforming Growth Factor-β Market Size (2021-2032) & (US$ Million) Figure 4. Global Recombinant Human Transforming Growth Factor-β Sales (2021-2032) & (K Units) Figure 5. Global Recombinant Human Transforming Growth Factor-β Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Recombinant Human Transforming Growth Factor-β Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. TGF-β3 Image Figure 9. TGF-β2 Image Figure 10. TGF-β1 Image Figure 11. Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Recombinant Human Transforming Growth Factor-β Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2021-2032) Figure 14. Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Research Institute Image Figure 19. Others Image Figure 20. Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Recombinant Human Transforming Growth Factor-β Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2021-2032) Figure 23. Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2021-2032) Figure 26. North America Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2032) Figure 28. U.S. Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2032) Figure 33. Germany Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2032) Figure 40. China Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Market Share by Country (2021-2032) Figure 48. Brazil Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Recombinant Human Transforming Growth Factor-β Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Recombinant Human Transforming Growth Factor-β Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Figure 59. North America Recombinant Human Transforming Growth Factor-β Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Figure 61. Europe Recombinant Human Transforming Growth Factor-β Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Recombinant Human Transforming Growth Factor-β Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Recombinant Human Transforming Growth Factor-β Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Recombinant Human Transforming Growth Factor-β Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • TGF-β3
  • TGF-β2
  • TGF-β1
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • Abcam
  • ACROBiosystems
  • Atlantis Bioscience
  • Bio-Techne
  • Cell Guidance Systems
  • Cell Signaling Technology
  • Croyez Bioscience
  • FUJIFILM Irvine Scientific
  • MedChemExpress
  • Miltenyi Biotec
  • Proteintech
  • Qkine
  • Sigma-Aldrich
  • Beijing T&L Biotechnology
  • Beijing Sino Biological
  • Dalian Meilun Biotechnology
  • Cellverse
  • Nanjing Okay Biotechnology
  • Thermo Fisher
  • Shanghai DiLab Biotechnology
  • Shanghai Zhong Qiao Xin Zhou Biotechnology
  • Suzhou Novoprotein Scientific
  • Abbkine Scientific
  • EIAAB SCIENCE
  • Yeasen Biotechnology (Shanghai)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Recombinant Human Transforming Growth Factor-β Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Recombinant Human Transforming Growth Factor-β Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Recombinant Human Transforming Growth Factor-β Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Recombinant Human Transforming Growth Factor-β Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Recombinant Human Transforming Growth Factor-β Market Dynamics
  1. 2.1 Recombinant Human Transforming Growth Factor-β Industry Trends
  2. 2.2 Recombinant Human Transforming Growth Factor-β Industry Drivers
  3. 2.3 Recombinant Human Transforming Growth Factor-β Industry Opportunities and Challenges
  4. 2.4 Recombinant Human Transforming Growth Factor-β Industry Restraints
3 Recombinant Human Transforming Growth Factor-β Market by Manufacturers
  1. 3.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Recombinant Human Transforming Growth Factor-β Sales by Manufacturers (2021-2026)
  3. 3.3 Global Recombinant Human Transforming Growth Factor-β Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Recombinant Human Transforming Growth Factor-β Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Recombinant Human Transforming Growth Factor-β Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Recombinant Human Transforming Growth Factor-β Manufacturers, Product Type & Application
  7. 3.7 Global Recombinant Human Transforming Growth Factor-β Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Recombinant Human Transforming Growth Factor-β Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Recombinant Human Transforming Growth Factor-β Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Recombinant Human Transforming Growth Factor-β Tier 1, Tier 2, and Tier 3
4 Recombinant Human Transforming Growth Factor-β Market by Type
  1. 4.1 Recombinant Human Transforming Growth Factor-β Type Introduction
  2. 4.1.1 TGF-β3
  3. 4.1.2 TGF-β2
  4. 4.1.3 TGF-β1
  5. 4.2 Global Recombinant Human Transforming Growth Factor-β Sales by Type
  6. 4.2.1 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Recombinant Human Transforming Growth Factor-β Sales by Type (2021-2032)
  8. 4.2.3 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Type (2021-2032)
  9. 4.3 Global Recombinant Human Transforming Growth Factor-β Revenue by Type
  10. 4.3.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Type (2021-2032)
  12. 4.3.3 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Type (2021-2032)
5 Recombinant Human Transforming Growth Factor-β Market by Application
  1. 5.1 Recombinant Human Transforming Growth Factor-β Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Research Institute
  4. 5.1.3 Others
  5. 5.2 Global Recombinant Human Transforming Growth Factor-β Sales by Application
  6. 5.2.1 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Recombinant Human Transforming Growth Factor-β Sales by Application (2021-2032)
  8. 5.2.3 Global Recombinant Human Transforming Growth Factor-β Sales Market Share by Application (2021-2032)
  9. 5.3 Global Recombinant Human Transforming Growth Factor-β Revenue by Application
  10. 5.3.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Application (2021-2032)
  12. 5.3.3 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Application (2021-2032)
6 Global Recombinant Human Transforming Growth Factor-β Sales by Region
  1. 6.1 Global Recombinant Human Transforming Growth Factor-β Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Recombinant Human Transforming Growth Factor-β Sales by Region (2021-2032)
  3. 6.2.1 Global Recombinant Human Transforming Growth Factor-β Sales by Region (2021-2026)
  4. 6.2.2 Global Recombinant Human Transforming Growth Factor-β Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Recombinant Human Transforming Growth Factor-β Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Recombinant Human Transforming Growth Factor-β Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Recombinant Human Transforming Growth Factor-β Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Recombinant Human Transforming Growth Factor-β Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Recombinant Human Transforming Growth Factor-β Revenue by Region
  1. 7.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Region
  2. 7.1.1 Global Recombinant Human Transforming Growth Factor-β Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Recombinant Human Transforming Growth Factor-β Revenue by Region (2021-2026)
  4. 7.1.3 Global Recombinant Human Transforming Growth Factor-β Revenue by Region (2027-2032)
  5. 7.1.4 Global Recombinant Human Transforming Growth Factor-β Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Recombinant Human Transforming Growth Factor-β Revenue (2021-2032)
  8. 7.2.2 North America Recombinant Human Transforming Growth Factor-β Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Recombinant Human Transforming Growth Factor-β Revenue (2021-2032)
  11. 7.3.2 Europe Recombinant Human Transforming Growth Factor-β Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Recombinant Human Transforming Growth Factor-β Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Recombinant Human Transforming Growth Factor-β Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Recombinant Human Transforming Growth Factor-β Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abcam
  2. 8.1.1 Abcam Company Information
  3. 8.1.2 Abcam Business Overview
  4. 8.1.3 Abcam Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abcam Recombinant Human Transforming Growth Factor-β Product Portfolio
  6. 8.1.5 Abcam Recent Developments
  7. 8.2 ACROBiosystems
  8. 8.2.1 ACROBiosystems Company Information
  9. 8.2.2 ACROBiosystems Business Overview
  10. 8.2.3 ACROBiosystems Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 ACROBiosystems Recombinant Human Transforming Growth Factor-β Product Portfolio
  12. 8.2.5 ACROBiosystems Recent Developments
  13. 8.3 Atlantis Bioscience
  14. 8.3.1 Atlantis Bioscience Company Information
  15. 8.3.2 Atlantis Bioscience Business Overview
  16. 8.3.3 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Atlantis Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
  18. 8.3.5 Atlantis Bioscience Recent Developments
  19. 8.4 Bio-Techne
  20. 8.4.1 Bio-Techne Company Information
  21. 8.4.2 Bio-Techne Business Overview
  22. 8.4.3 Bio-Techne Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bio-Techne Recombinant Human Transforming Growth Factor-β Product Portfolio
  24. 8.4.5 Bio-Techne Recent Developments
  25. 8.5 Cell Guidance Systems
  26. 8.5.1 Cell Guidance Systems Company Information
  27. 8.5.2 Cell Guidance Systems Business Overview
  28. 8.5.3 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cell Guidance Systems Recombinant Human Transforming Growth Factor-β Product Portfolio
  30. 8.5.5 Cell Guidance Systems Recent Developments
  31. 8.6 Cell Signaling Technology
  32. 8.6.1 Cell Signaling Technology Company Information
  33. 8.6.2 Cell Signaling Technology Business Overview
  34. 8.6.3 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Cell Signaling Technology Recombinant Human Transforming Growth Factor-β Product Portfolio
  36. 8.6.5 Cell Signaling Technology Recent Developments
  37. 8.7 Croyez Bioscience
  38. 8.7.1 Croyez Bioscience Company Information
  39. 8.7.2 Croyez Bioscience Business Overview
  40. 8.7.3 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Croyez Bioscience Recombinant Human Transforming Growth Factor-β Product Portfolio
  42. 8.7.5 Croyez Bioscience Recent Developments
  43. 8.8 FUJIFILM Irvine Scientific
  44. 8.8.1 FUJIFILM Irvine Scientific Company Information
  45. 8.8.2 FUJIFILM Irvine Scientific Business Overview
  46. 8.8.3 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 FUJIFILM Irvine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  48. 8.8.5 FUJIFILM Irvine Scientific Recent Developments
  49. 8.9 MedChemExpress
  50. 8.9.1 MedChemExpress Company Information
  51. 8.9.2 MedChemExpress Business Overview
  52. 8.9.3 MedChemExpress Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MedChemExpress Recombinant Human Transforming Growth Factor-β Product Portfolio
  54. 8.9.5 MedChemExpress Recent Developments
  55. 8.10 Miltenyi Biotec
  56. 8.10.1 Miltenyi Biotec Company Information
  57. 8.10.2 Miltenyi Biotec Business Overview
  58. 8.10.3 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Miltenyi Biotec Recombinant Human Transforming Growth Factor-β Product Portfolio
  60. 8.10.5 Miltenyi Biotec Recent Developments
  61. 8.11 Proteintech
  62. 8.11.1 Proteintech Company Information
  63. 8.11.2 Proteintech Business Overview
  64. 8.11.3 Proteintech Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Proteintech Recombinant Human Transforming Growth Factor-β Product Portfolio
  66. 8.11.5 Proteintech Recent Developments
  67. 8.12 Qkine
  68. 8.12.1 Qkine Company Information
  69. 8.12.2 Qkine Business Overview
  70. 8.12.3 Qkine Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Qkine Recombinant Human Transforming Growth Factor-β Product Portfolio
  72. 8.12.5 Qkine Recent Developments
  73. 8.13 Sigma-Aldrich
  74. 8.13.1 Sigma-Aldrich Company Information
  75. 8.13.2 Sigma-Aldrich Business Overview
  76. 8.13.3 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sigma-Aldrich Recombinant Human Transforming Growth Factor-β Product Portfolio
  78. 8.13.5 Sigma-Aldrich Recent Developments
  79. 8.14 Beijing T&L Biotechnology
  80. 8.14.1 Beijing T&L Biotechnology Company Information
  81. 8.14.2 Beijing T&L Biotechnology Business Overview
  82. 8.14.3 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Beijing T&L Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  84. 8.14.5 Beijing T&L Biotechnology Recent Developments
  85. 8.15 Beijing Sino Biological
  86. 8.15.1 Beijing Sino Biological Company Information
  87. 8.15.2 Beijing Sino Biological Business Overview
  88. 8.15.3 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Beijing Sino Biological Recombinant Human Transforming Growth Factor-β Product Portfolio
  90. 8.15.5 Beijing Sino Biological Recent Developments
  91. 8.16 Dalian Meilun Biotechnology
  92. 8.16.1 Dalian Meilun Biotechnology Company Information
  93. 8.16.2 Dalian Meilun Biotechnology Business Overview
  94. 8.16.3 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Dalian Meilun Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  96. 8.16.5 Dalian Meilun Biotechnology Recent Developments
  97. 8.17 Cellverse
  98. 8.17.1 Cellverse Company Information
  99. 8.17.2 Cellverse Business Overview
  100. 8.17.3 Cellverse Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Cellverse Recombinant Human Transforming Growth Factor-β Product Portfolio
  102. 8.17.5 Cellverse Recent Developments
  103. 8.18 Nanjing Okay Biotechnology
  104. 8.18.1 Nanjing Okay Biotechnology Company Information
  105. 8.18.2 Nanjing Okay Biotechnology Business Overview
  106. 8.18.3 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Nanjing Okay Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  108. 8.18.5 Nanjing Okay Biotechnology Recent Developments
  109. 8.19 Thermo Fisher
  110. 8.19.1 Thermo Fisher Company Information
  111. 8.19.2 Thermo Fisher Business Overview
  112. 8.19.3 Thermo Fisher Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Thermo Fisher Recombinant Human Transforming Growth Factor-β Product Portfolio
  114. 8.19.5 Thermo Fisher Recent Developments
  115. 8.20 Shanghai DiLab Biotechnology
  116. 8.20.1 Shanghai DiLab Biotechnology Company Information
  117. 8.20.2 Shanghai DiLab Biotechnology Business Overview
  118. 8.20.3 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Shanghai DiLab Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  120. 8.20.5 Shanghai DiLab Biotechnology Recent Developments
  121. 8.21 Shanghai Zhong Qiao Xin Zhou Biotechnology
  122. 8.21.1 Shanghai Zhong Qiao Xin Zhou Biotechnology Company Information
  123. 8.21.2 Shanghai Zhong Qiao Xin Zhou Biotechnology Business Overview
  124. 8.21.3 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Shanghai Zhong Qiao Xin Zhou Biotechnology Recombinant Human Transforming Growth Factor-β Product Portfolio
  126. 8.21.5 Shanghai Zhong Qiao Xin Zhou Biotechnology Recent Developments
  127. 8.22 Suzhou Novoprotein Scientific
  128. 8.22.1 Suzhou Novoprotein Scientific Company Information
  129. 8.22.2 Suzhou Novoprotein Scientific Business Overview
  130. 8.22.3 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Suzhou Novoprotein Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  132. 8.22.5 Suzhou Novoprotein Scientific Recent Developments
  133. 8.23 Abbkine Scientific
  134. 8.23.1 Abbkine Scientific Company Information
  135. 8.23.2 Abbkine Scientific Business Overview
  136. 8.23.3 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Abbkine Scientific Recombinant Human Transforming Growth Factor-β Product Portfolio
  138. 8.23.5 Abbkine Scientific Recent Developments
  139. 8.24 EIAAB SCIENCE
  140. 8.24.1 EIAAB SCIENCE Company Information
  141. 8.24.2 EIAAB SCIENCE Business Overview
  142. 8.24.3 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 EIAAB SCIENCE Recombinant Human Transforming Growth Factor-β Product Portfolio
  144. 8.24.5 EIAAB SCIENCE Recent Developments
  145. 8.25 Yeasen Biotechnology (Shanghai)
  146. 8.25.1 Yeasen Biotechnology (Shanghai) Company Information
  147. 8.25.2 Yeasen Biotechnology (Shanghai) Business Overview
  148. 8.25.3 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Yeasen Biotechnology (Shanghai) Recombinant Human Transforming Growth Factor-β Product Portfolio
  150. 8.25.5 Yeasen Biotechnology (Shanghai) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Recombinant Human Transforming Growth Factor-β Value Chain Analysis
  2. 9.1.1 Recombinant Human Transforming Growth Factor-β Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Recombinant Human Transforming Growth Factor-β Production Mode & Process
  6. 9.2 Recombinant Human Transforming Growth Factor-β Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Recombinant Human Transforming Growth Factor-β Distributors
  9. 9.2.3 Recombinant Human Transforming Growth Factor-β Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst